T CELL IMMUNOTHERAPY DERIVED FROM HIGHLY FUNCTIONAL AUTOLOGOUS STEM

T CELL IMMUNOTHERAPY DERIVED FROM HIGHLY FUNCTIONAL AUTOLOGOUS STEM

The present invention relates to a new and specific T-cell therapy strategy based on the use of memory stem T-cells (Tscm), in particular highly functional memory stem T-cells (Tscm) negatively selected on the basis of inhibitory receptor expression. This new cellular immunotherapy may be applied to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: TAOUFIK, Yassine, DE GOËR DE HERVE, Marie-Ghislaine Madeleine
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator TAOUFIK, Yassine
DE GOËR DE HERVE, Marie-Ghislaine Madeleine
description The present invention relates to a new and specific T-cell therapy strategy based on the use of memory stem T-cells (Tscm), in particular highly functional memory stem T-cells (Tscm) negatively selected on the basis of inhibitory receptor expression. This new cellular immunotherapy may be applied to PML patients but also to other infections or cancers for which the specific memory T cell responses are functionally impaired.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP4423247A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP4423247A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP4423247A13</originalsourceid><addsrcrecordid>eNrjZHAOUXB29fFR8PT1DfXzD_FwDXIMiFRwcQ3yDHN1UXAL8vdV8PB09_CJVHAL9XMO8fT3c_RRcAwN8ffxd_cPDVYIDnH15WFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BJiZGxkYm5o6GxkQoAQD3zitm</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>T CELL IMMUNOTHERAPY DERIVED FROM HIGHLY FUNCTIONAL AUTOLOGOUS STEM</title><source>esp@cenet</source><creator>TAOUFIK, Yassine ; DE GOËR DE HERVE, Marie-Ghislaine Madeleine</creator><creatorcontrib>TAOUFIK, Yassine ; DE GOËR DE HERVE, Marie-Ghislaine Madeleine</creatorcontrib><description>The present invention relates to a new and specific T-cell therapy strategy based on the use of memory stem T-cells (Tscm), in particular highly functional memory stem T-cells (Tscm) negatively selected on the basis of inhibitory receptor expression. This new cellular immunotherapy may be applied to PML patients but also to other infections or cancers for which the specific memory T cell responses are functionally impaired.</description><language>eng ; fre ; ger</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240904&amp;DB=EPODOC&amp;CC=EP&amp;NR=4423247A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240904&amp;DB=EPODOC&amp;CC=EP&amp;NR=4423247A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TAOUFIK, Yassine</creatorcontrib><creatorcontrib>DE GOËR DE HERVE, Marie-Ghislaine Madeleine</creatorcontrib><title>T CELL IMMUNOTHERAPY DERIVED FROM HIGHLY FUNCTIONAL AUTOLOGOUS STEM</title><description>The present invention relates to a new and specific T-cell therapy strategy based on the use of memory stem T-cells (Tscm), in particular highly functional memory stem T-cells (Tscm) negatively selected on the basis of inhibitory receptor expression. This new cellular immunotherapy may be applied to PML patients but also to other infections or cancers for which the specific memory T cell responses are functionally impaired.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHAOUXB29fFR8PT1DfXzD_FwDXIMiFRwcQ3yDHN1UXAL8vdV8PB09_CJVHAL9XMO8fT3c_RRcAwN8ffxd_cPDVYIDnH15WFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BJiZGxkYm5o6GxkQoAQD3zitm</recordid><startdate>20240904</startdate><enddate>20240904</enddate><creator>TAOUFIK, Yassine</creator><creator>DE GOËR DE HERVE, Marie-Ghislaine Madeleine</creator><scope>EVB</scope></search><sort><creationdate>20240904</creationdate><title>T CELL IMMUNOTHERAPY DERIVED FROM HIGHLY FUNCTIONAL AUTOLOGOUS STEM</title><author>TAOUFIK, Yassine ; DE GOËR DE HERVE, Marie-Ghislaine Madeleine</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP4423247A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2024</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>TAOUFIK, Yassine</creatorcontrib><creatorcontrib>DE GOËR DE HERVE, Marie-Ghislaine Madeleine</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TAOUFIK, Yassine</au><au>DE GOËR DE HERVE, Marie-Ghislaine Madeleine</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>T CELL IMMUNOTHERAPY DERIVED FROM HIGHLY FUNCTIONAL AUTOLOGOUS STEM</title><date>2024-09-04</date><risdate>2024</risdate><abstract>The present invention relates to a new and specific T-cell therapy strategy based on the use of memory stem T-cells (Tscm), in particular highly functional memory stem T-cells (Tscm) negatively selected on the basis of inhibitory receptor expression. This new cellular immunotherapy may be applied to PML patients but also to other infections or cancers for which the specific memory T cell responses are functionally impaired.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP4423247A1
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
title T CELL IMMUNOTHERAPY DERIVED FROM HIGHLY FUNCTIONAL AUTOLOGOUS STEM
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T04%3A40%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TAOUFIK,%20Yassine&rft.date=2024-09-04&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP4423247A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true